Postma DS - Search Results

1

Definitions of exacerbations: does it really matter in clinical trials on COPD?

Effing TW, Kerstjens HAM, Monninkhof EM, van der Valk PDLPM, Wouters EFM, Postma DS, Zielhuis GA, van der Palen J. Effing TW, et al. Among authors: postma ds. Chest. 2009 Sep;136(3):918-923. doi: 10.1378/chest.08-1680. Chest. 2009. PMID: 19736196 Review.

2

Oral or IV prednisolone in the treatment of COPD exacerbations: a randomized, controlled, double-blind study.

de Jong YP, Uil SM, Grotjohan HP, Postma DS, Kerstjens HA, van den Berg JW. de Jong YP, et al. Among authors: postma ds. Chest. 2007 Dec;132(6):1741-7. doi: 10.1378/chest.07-0208. Epub 2007 Jul 23. Chest. 2007. PMID: 17646228 Clinical Trial.

3

Increased systemic inflammation is a risk factor for COPD exacerbations.

Groenewegen KH, Postma DS, Hop WC, Wielders PL, Schlösser NJ, Wouters EF; COSMIC Study Group. Groenewegen KH, et al. Among authors: postma ds. Chest. 2008 Feb;133(2):350-7. doi: 10.1378/chest.07-1342. Epub 2008 Jan 15. Chest. 2008. PMID: 18198263 Clinical Trial.

4

Copd.

Kerstjens HA, Postma DS, Ten Hacken N. Kerstjens HA, et al. Among authors: postma ds. BMJ Clin Evid. 2008 Dec 15;2008:1502. BMJ Clin Evid. 2008. PMID: 19445783 Free PMC article. Review.

5

Relapse in FEV1 Decline After Steroid Withdrawal in COPD.

Kunz LIZ, Postma DS, Klooster K, Lapperre TS, Vonk JM, Sont JK, Kerstjens HAM, Snoeck-Stroband JB, Hiemstra PS, Sterk PJ; GLUCOLD Study Group. Kunz LIZ, et al. Among authors: postma ds. Chest. 2015 Aug;148(2):389-396. doi: 10.1378/chest.14-3091. Chest. 2015. PMID: 25836351 Clinical Trial.

6

Inhaled corticosteroids and long-acting beta-agonists in adult asthma: a winning combination in all?

Postma DS, Kerstjens HA, ten Hacken NH. Postma DS, et al. Naunyn Schmiedebergs Arch Pharmacol. 2008 Aug;378(2):203-15. doi: 10.1007/s00210-008-0302-y. Epub 2008 May 24. Naunyn Schmiedebergs Arch Pharmacol. 2008. PMID: 18500509 Free PMC article. Retracted. Review.

7

Anti-inflammatory effects of combined budesonide/formoterol in COPD exacerbations.

Bathoorn E, Liesker JJ, Postma DS, Boorsma M, Bondesson E, Koëter GH, Kauffman HF, van Oosterhout AJ, Kerstjens HA. Bathoorn E, et al. Among authors: postma ds. COPD. 2008 Oct;5(5):282-90. doi: 10.1080/15412550802363360. COPD. 2008. PMID: 18972276 Clinical Trial.

8

Inhaled corticosteroids in chronic obstructive pulmonary disease: a review.

Telenga ED, Kerstjens HA, Postma DS, Ten Hacken NH, van den Berge M. Telenga ED, et al. Among authors: postma ds. Expert Opin Pharmacother. 2010 Feb;11(3):405-21. doi: 10.1517/14656560903510628. Expert Opin Pharmacother. 2010. PMID: 20102305 Review.

9

Beneficial effects of treatment with anti-IgE antibodies (Omalizumab) in a patient with severe asthma and negative skin-prick test results.

van den Berge M, Pauw RG, de Monchy JG, van Minnen CA, Postma DS, Kerstjens HA. van den Berge M, et al. Among authors: postma ds. Chest. 2011 Jan;139(1):190-3. doi: 10.1378/chest.10-0128. Chest. 2011. PMID: 21208879

10

Sputum inflammation predicts exacerbations after cessation of inhaled corticosteroids in COPD.

Liesker JJ, Bathoorn E, Postma DS, Vonk JM, Timens W, Kerstjens HA. Liesker JJ, et al. Among authors: postma ds. Respir Med. 2011 Dec;105(12):1853-60. doi: 10.1016/j.rmed.2011.07.002. Epub 2011 Jul 29. Respir Med. 2011. PMID: 21802933 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

897 results

Search Page